Overview

Sodium Hyaluronate Ophthalmic Solution, 0.18% for Treatment of Dry Eye Syndrome

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study was to determine if Sodium Hyaluronate, 0.18% is effective in treating the signs and symptoms of dry eye disease.
Phase:
Phase 3
Details
Lead Sponsor:
Alcon Research
Treatments:
Hyaluronic Acid
Ophthalmic Solutions
Pharmaceutical Solutions